Ivica, Josko; Gauthier, Jeannette; Power, Patricia; Lamy, Andre; Potter, Murray published an article about the compound: cis-4-Aminocyclohexane carboxylic acid( cas:3685-23-2,SMILESS:N[C@H]1CC[C@H](CC1)C(O)=O ).Product Details of 3685-23-2. Aromatic heterocyclic compounds can be classified according to the number of heteroatoms or the size of the ring. The authors also want to convey more information about this compound (cas:3685-23-2) through the article.
Tranexamic acid is a drug used during open cardiac surgery to prevent blood loss. The blood levels of 10-100μg/mL are reported to be in the therapeutic range and higher levels are linked to increased incidence of adverse effects. The aim of this study was to optimize and validate an LC-MS/MS method for serum tranexamic acid and measure its levels in patients from the DEPOSITION Pilot trial in order to prove the concept that topical administration will yield lower serum concentration The method development was carried out in several steps including sample preparation, and optimization of chromatog. and tandem mass spectrometry parameters. Method validation including day-to-day precision with 4 QC levels, limit of detection, sample stability, carryover, and concentration-signal linearity was carried out. Ninety patient samples were analyzed using the validated method. Fast and efficient LC-MS/MS method for anal. of tranexamic acid in serum was developed. The run time was 7 min with the total time of one hour including the sample preparation The method precision was acceptable (%CV = 10.5-12.6%) with no sample carryover observed The matrix effect on the anal. sensitivity was negligible and the lower limit of detection was 0.5μg/mL. The difference in the mean adjusted concentrations between topical (45 patients) and i.v. (45 patients) groups was statistically significant (0.1154μg/mL/kg vs. 0.2542μg/mL/kg, p < 0.0001). Rapid and simple LC-MS/MS method for anal. of tranexamic acid was optimized and validated. The laboratory has played a crucial role in proving the concept that topical administration yields significantly lower systemic levels of tranexamic acid, and thus decreases the risk of adverse outcomes in patients undergoing open cardiac surgery. This literature about this compound(3685-23-2)Product Details of 3685-23-2has given us a lot of inspiration, and I hope that the research on this compound(cis-4-Aminocyclohexane carboxylic acid) can be further advanced. Maybe we can get more compounds in a similar way.
Reference:
Synthesis and Crystal Structure of a Chiral C3-Symmetric Oxygen Tripodal Ligand and Its Applications to Asymmetric Catalysis,
Chiral lanthanide(III) complexes of sulphur–nitrogen–oxygen ligand derived from aminothiourea and sodium D-camphor-β-sulfonate